Apollon Wealth Management’s BioXcel Therapeutics BTAI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-636	Closed	-$6.2K	–	1201
2024 Q3	$6.2K	Sell	636 -15	-2%	-$146	﹤0.01%	1130
2024 Q2	$13.3K	Buy	651 +15	+2%	+$307	﹤0.01%	1095
2024 Q1	$28.7K	Sell	636 -23	-3%	-$1.04K	﹤0.01%	1096
2023 Q4	$31.1K	Buy	+659	New	+$31.1K	﹤0.01%	1056